Brief: Cipher Pharmaceuticals acquires worldwide rights to Dalhousie University's investigational tattoo removal cream
02/05/2016 14:31
May 2 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* Cipher Pharmaceuticals acquires worldwide rights to
Dalhousie University's investigational tattoo removal cream
Source text for Eikon: ID:nCNWJSz8la
Further company coverage: CPH.TO
((Bengaluru Newsroom +1 646 223 8780;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million